Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:2423-2425
doi: 10.1161/hs1001.098155
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boysen, G.
Right arrow Articles by Christensen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boysen, G.
Right arrow Articles by Christensen, H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke

(Stroke. 2001;32:2423.)
© 2001 American Heart Association, Inc.


Comments, Opinions, and Reviews

Early Stroke: A Dynamic Process

Gudrun Boysen, MD, MDSc Hanne Christensen, MD

From the Department of Neurology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Correspondence to Gudrun Boysen, MD, Department of Neurology, Bispebjerg Hospital, 2400 Copenhagen, Denmark. E-mail gb01@bbh.hosp.dk


Key Words: stroke • stroke onset • stroke, acute


*    Introduction
 
In the acutely infarcted brain, cytokines are released into cerebrospinal fluid and blood. Interleukin (IL)-1ß, IL-6, and tumor necrosis factor (TNF)-{alpha}, among others, may play a role in the acute increases in plasma adrenocorticotropic hormone, cortisol, epinephrine, norepinephrine, and vasopressin.1–6 Increases in cytokines and hormones may in turn induce changes in other variables. When recorded on admission in acute stroke patients, many variables have been found to be associated with poor outcome in acute stroke. Body temperature7 is one such variable, blood glucose another,8–18 and C-reactive protein (CRP)19–22 and white blood cell count (WBC)20,23 serum cortisol and ferritin24 are further examples. Elevated plasma and cerebrospinal fluid levels of glutamate, glycine,25 ferritin,26 and IL-627 were also associated with deteriorating stroke.

It seems plausible that these variables generally are unaffected at stroke onset and then increase in the early hours after onset, depending on the severity of the stroke. We found this to be the case with temperature,28 which in a large series of patients was normal when measured within 2 hours of stroke onset, but which rose at 4 to 6 hours after stroke onset in patients with severe neurological deficits. At 8 to 10 hours after stroke onset, elevated temperature was associated with poor outcome. This association arose several hours after onset of severe stroke. Thus, the initial severity of the stroke preceded the increase in temperature.

Many studies on blood glucose and stroke prognosis share the same kind of problem. In most studies, blood glucose was measured fairly . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
J. Prosser, L. MacGregor, K. R. Lees, H.-C. Diener, W. Hacke, S. Davis, and on behalf of the VISTA Investigators
Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke
Stroke, August 1, 2007; 38(8): 2295 - 2302.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Di Napoli
Editorial Comment--How to Search for the Role of Genetic Polymorphisms in Stroke: Theory Versus Practice
Stroke, August 1, 2003; 34(8): 1869 - 1870.
[Full Text] [PDF]


Home page
StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]